Floatz logo

Wellbutrin

Uterine Corpus Cancer

NRG OncologyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Uterine Corpus Cancer cohort.

Asset / SponsorPhaseRating
Doxycycline
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC
Metformin
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC

Same molecule, other indications

Wellbutrin is also rated in:

Smoking CessationDormant
A
Indicative ·
82 / 100
View asset →
DysthymiaDormant
BBB
Indicative ·
73 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →